U.S. Bolsters Ebola Response with $50 Million Aid to CEPI

The U.S. is allocating $50 million to CEPI for developing medical countermeasures targeting the rare Bundibugyo strain of Ebola. This initiative aims to support research and manufacturing efforts in curbing the outbreak in Africa, particularly affecting the Democratic Republic of Congo and Uganda.

The United States has announced a significant $50 million investment to support the Coalition for Epidemic Preparedness Innovations (CEPI) in developing countermeasures against a rare Ebola strain causing havoc in Africa, according to the State Department.

This financial aid aims to back laboratory studies, clinical trials, and manufacturing efforts to combat the Bundibugyo strain of Ebola. This latest contribution raises the State Department's total funding in the Ebola response to $270 million. Concurrently, CEPI has dedicated over $60 million for four vaccine efforts, with more under evaluation.

Dr. Richard Hatchett, CEO of CEPI, emphasized the urgency in developing vaccines for the Bundibugyo virus which currently lacks licensed vaccines. The outbreak has led to 676 confirmed cases and 136 deaths in Congo, and has spread to Uganda with 19 cases. The delayed detection has posed challenges for first responders.